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Background: Elevated pulmonary vascular resistance (>5 wood units, WU) is a contraindication for heart transplantation. LVADs and 
inotropes have been used to reduce PVR to allow transplantation. However, little is known about the efficacy of this strategy.
methods: We queried the UNOS registry for all adult patients (age > 18) listed for heart transplant with pulmonary vascular resistance of > 
5 WU who have LVAD or on intravenous inotropic support with status 1a, 1b or 7.
results: We identified 945 patients, males (67.0%), Caucasians (51.5%) with mean listing age of 51.7 years. Listing status was 1a 
(29.0%), 1b (67.1%) and 7 (3.9%). Most patients were on inotropes (80.4%) and 25.5% had LVADs at listing. Compared with the inotrope 
group, LVAD patients were more likely to have status 1a and 7 (p<0.001), lower PVR (p=0.001) and higher cardiac output (p=0.001). After 
a mean of 187.1 days, PVR decreased by 2.9 WU in LVAD group compared with 2.5 WU in inotrope group, p=0.26. 34.5% of patients with 
LVAD had reduction in PVR to less than 5 WU compared to 44.0% with inotrope, p=0.076. Transplant and wait list mortality were similar 
between groups (p=0.06). A total of 733 patients received heart transplantation. Patients bridged with LVADs had worse post-transplant 
graft survival (log-rank p=0.012).
conclusion:  PVRs normalize with LVAD or inotropes in less than half of the patients. Inotropes are similar to VADs in decreasing PVR, 
however, patients bridged with inotropes may have better post-transplant graft survival.
 
